Alaethes Wealth LLC Novo Nordisk A S Transaction History

Alaethes Wealth LLC

$264 Million
Q4 2024

A detailed history of Alaethes Wealth LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Alaethes Wealth LLC holds 24,922 shares of NVO stock, worth $2.08 Million. This represents 0.81% of its overall portfolio holdings.

Number of Shares

24,922

Previous 24,666 1.04%

Holding current value

$2.08 Million

Previous $2.94 Million 27.01%

% of portfolio

0.81%

Previous 1.13%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$85.0 - $120.04 $21,760 - $30,730	256 Added 1.04%	24,922 $2.14 Million
Q3 2024 Nov 14, 2024	BUY	$119.07 - $145.42 $44,413 - $54,241	373 Added 1.54%	24,666 $2.94 Million
Q2 2024 Aug 13, 2024	BUY	$122.71 - $146.91 $41,230 - $49,361	336 Added 1.4%	24,293 $3.47 Million
Q1 2024 May 15, 2024	BUY	$102.11 - $135.92 $155,615 - $207,142	1,524 Added 6.79%	23,957 $3.08 Million
Q4 2023 Feb 12, 2024	BUY	$87.78 - $105.45 $40,378 - $48,507	460 Added 2.09%	22,433 $2.32 Million
Q3 2023 Nov 13, 2023	BUY	$90.94 - $199.54 $1.08 Million - $2.37 Million	11,881 Added 117.73%	21,973 $2 Million
Q2 2023 Aug 14, 2023	SELL	$155.98 - $172.65 $65,511 - $72,513	-420 Reduced 4.0%	10,092 $1.63 Million
Q1 2023 May 15, 2023	BUY	$132.34 - $159.14 $51,347 - $61,746	388 Added 3.83%	10,512 $1.67 Million
Q4 2022 Feb 13, 2023	BUY	$102.55 - $135.33 $10,665 - $14,074	104 Added 1.04%	10,124 $1.37 Million
Q3 2022 Nov 14, 2022	BUY	$95.28 - $116.93 $47,449 - $58,231	498 Added 5.23%	10,020 $998,000
Q2 2022 Aug 16, 2022	BUY	$103.24 - $121.81 $47,903 - $56,519	464 Added 5.12%	9,522 $1.06 Million
Q1 2022 May 16, 2022	BUY	$93.1 - $112.54 $127,640 - $154,292	1,371 Added 17.84%	9,058 $1.01 Million
Q4 2021 Feb 15, 2022	BUY	$95.88 - $117.08 $737,029 - $899,993	7,687 New	7,687 $861,000

Others Institutions Holding NVO

# of Institutions

1,876

Shares Held

336M

Call Options Held

11.9M

Put Options Held

10.6M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $188B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alaethes Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alaethes Wealth LLC with notifications on news.

Account

Alaethes Wealth LLC Novo Nordisk A S Transaction History